Showing results (941-950 of 16,170) with videos related to

Sort By:
Pageof 1,617
European Journal of Medicinal Chemistry|January 7, 2022
Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's diseaseWenwu Liu, Xin Liu, Wenjie Liu, et al.
European Journal of Medicinal Chemistry|January 8, 2022
Discovery of a tricyclic farnesoid X receptor agonist HEC96719, a clinical candidate for treatment of non-alcoholic steatohepatitisShengtian Cao, Xinye Yang, Zheng Zhang, et al.
European Journal of Medicinal Chemistry|January 8, 2022
Synthesis of novel thiazolyl hydrazone derivatives as potent dual monoamine oxidase-aromatase inhibitorsAsaf Evrim Evren, Demokrat Nuha, Sam Dawbaa, et al.
European Journal of Medicinal Chemistry|August 26, 2022
Disulfiram and dithiocarbamate analogues demonstrate promising antischistosomal effectsGeorg A Rennar, Tom L Gallinger, Patrick Mäder, et al.
European Journal of Medicinal Chemistry|October 20, 2022
Advances of targeting the YAP/TAZ-TEAD complex in the hippo pathway for the treatment of cancersMengxin Luo, Yongjin Xu, Haifeng Chen, et al.
European Journal of Medicinal Chemistry|October 20, 2022
Recent molecular design strategies for efficient photodynamic therapy and its synergistic therapy based on AIE photosensitizersJinxi Liu, Wenting Chen, Caiyun Zheng, et al.
European Journal of Medicinal Chemistry|October 21, 2022
Novel nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studiesYingda Zang, Lei Huang, Xinyi Chen, et al.
European Journal of Medicinal Chemistry|October 24, 2022
A bibliometric analysis of PROTAC from 2001 to 2021Deping Li, Dongmin Yu, Yan Li, et al.
European Journal of Medicinal Chemistry|October 24, 2022
Medicinal chemistry strategies targeting PRMT5 for cancer therapySiyu Fu, Qinwen Zheng, Dan Zhang, et al.
European Journal of Medicinal Chemistry|October 24, 2022
Synthesis, docking, and biological evaluation of novel 1-benzyl-4-(4-(R)-5-sulfonylidene-4,5-dihydro-1H-1,2,4-triazol-3-yl)pyrrolidin-2-ones as potential nootropic agentsAnton P Semenets, Marharyta M Suleiman, Andrii I Fedosov, et al.
Pageof 1,617